These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3196358)

  • 21. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2(High) receptors on intact cells.
    Seeman P
    Synapse; 2008 Apr; 62(4):314-8. PubMed ID: 18241049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.
    Seeman P; Guan HC; Hirbec H
    Synapse; 2009 Aug; 63(8):698-704. PubMed ID: 19391150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.
    Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE
    Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of [3H](-)-DO 710 as selective dopaminergic ligand for binding and autoradiographic studies.
    Sokoloff P; Brann M; Redouane K; Martres MP; Schwartz JC; Bouthenet ML; Sales N; Mann A; Hamdi P; Wermuth CG
    Eur J Pharmacol; 1985 Jan; 107(2):243-51. PubMed ID: 3979426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2(High) receptor.
    Seeman P; Guan HC
    Synapse; 2009 Oct; 63(10):935-9. PubMed ID: 19588471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrastructural localization of dopaminergic receptors in the rat corpus striatum by radioautography using tritiated domperidone].
    Arluison M; Martres MP; Sokoloff P
    C R Seances Soc Biol Fil; 1982; 176(1):23-9. PubMed ID: 6461391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
    Richfield EK; Young AB; Penney JB
    Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascorbic acid, redox cycling, lipid peroxidation, and the binding of dopamine receptor antagonists.
    Heikkila RE; Manzino L
    Ann N Y Acad Sci; 1987; 498():63-76. PubMed ID: 3476003
    [No Abstract]   [Full Text] [Related]  

  • 39. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P; Zwiller J; Malviya AN; Vincendon G
    Biochem Int; 1990 Nov; 22(3):575-82. PubMed ID: 1981673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.